The COVID-19 pandemic has accelerated the globalization of the life sciences industry, driving cross-border collaborations to develop urgently needed treatments, scale up manufacturing and distribution, and fill raw material...more
11/4/2022
/ Asset Seizure ,
Drug Pricing ,
Emerging Markets ,
Enforcement Actions ,
Food and Drug Administration (FDA) ,
Foreign Direct Investment ,
ICSID ,
Investment ,
Life Sciences ,
NAFTA ,
New York Convention ,
Patent Litigation ,
Patents ,
Risk Mitigation ,
Supply Shortages ,
Treaties